|
1
|
Coindre JM, Pédeutour F and Aurias A:
Well-differentiated and dedifferentiated liposarcomas. Virchows
Arch. 456:167–179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dalal KM, Antonescu CR and Singer S:
Diagnosis and management of lipomatous tumors. J Surg Oncol.
97:298–313. 2008. View Article : Google Scholar
|
|
3
|
Dei Tos AP: Liposarcoma: new entities and
evolving concepts. Ann Diagn Pathol. 4:252–266. 2000.PubMed/NCBI
|
|
4
|
Italiano A, Bianchini L, Keslair F,
Bonnafous S, Cardot-Leccia N, Coindre JM, Dumollard JM, Hofman P,
Leroux A, Mainguené C, Peyrottes I, Ranchere-Vince D, Terrier P,
Tran A, Gual P and Pedeutour F: HMGA2 is the partner of MDM2 in
well-differentiated and dedifferentiated liposarcomas whereas CDK4
belongs to a distinct inconsistent amplicon. Int J Cancer.
122:2233–2241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Antonescu CR, Elahi A, Humphrey M, Lui MY,
Healey JH, Brennan MF, Woodruff JM, Jhanwar SC and Ladanyi M:
Specificity of TLS-CHOP rearrangement for classic myxoid/round cell
liposarcoma: absence in predominantly myxoid well-differentiated
liposarcomas. J Mol Diagn. 2:132–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pilotti S, Della Torre G, Lavarino C,
Sozzi G, Minoletti F, Vergani B, Azzarelli A, Rilke F and Pierotti
MA: Molecular abnormalities in liposarcoma: role of MDM2 and
CDK4-containing amplicons at 12q13–22. J Pathol. 185:188–190.
1998.PubMed/NCBI
|
|
7
|
Berner JM, Forus A, Elkahloun A, Meltzer
PS, Fodstad O and Myklebost O: Separate amplified regions
encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes
Cancer. 17:254–259. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cannizzaro LA, Croce CM, Griffin CA,
Simeone A, Boncinelli E and Huebner K: Human homeo box-containing
genes located at chromosome regions 2q31----2q37 and
12q12----12q13. Am J Hum Genet. 41:1–15. 1987.PubMed/NCBI
|
|
9
|
Gehring WJ and Hiromi Y: Homeotic genes
and the homeobox. Annu Rev Genet. 20:147–173. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Apiou F, Flagiello D, Cillo C, Malfoy B,
Poupon MF and Dutrillaux B: Fine mapping of human HOX gene
clusters. Cytogenet Cell Genet. 73:114–115. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cillo C: HOX genes in human cancers.
Invasion Metastasis. 14:38–49. 1994–1995.PubMed/NCBI
|
|
12
|
Cillo C, Faiella A, Cantile M and
Boncinelli E: Homeobox genes and cancer. Exp Cell Res. 248:1–9.
1999. View Article : Google Scholar
|
|
13
|
Nunes FD, de Almeida FC, Tucci R and de
Sousa SC: Homeobox genes: a molecular link between development and
cancer. Pesqui Odontol Bras. 17:94–98. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grier DG, Thompson A, Kwasniewska A,
McGonigle GJ, Halliday HL and Lappin TR: The pathophysiology of HOX
genes and their role in cancer. J Pathol. 205:154–171. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Argiropoulos B and Humphries RK: Hox genes
in hematopoiesis and leukemogenesis. Oncogene. 26:6766–6776. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shah N and Sukumar S: The Hox genes and
their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cantile M, Pettinato G, Procino A,
Feliciello I, Cindolo L and Cillo C: In vivo expression of the
whole HOX gene network in human breast cancer. Eur J Cancer.
39:257–264. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cantile M, Kisslinger A, Cindolo L,
Schiavo G, D’Antò V, Franco R, Altieri V, Gallo A, Villacci A,
Tramontano D and Cillo C: cAMP induced modifications of HOX D gene
expression in prostate cells allow the identification of a
chromosomal area involved in vivo with neuroendocrine
differentiation of human advanced prostate cancers. J Cell Physiol.
205:202–210. 2005. View Article : Google Scholar
|
|
19
|
Cantile M, Franco R, Tschan A, Baumhoer D,
Zlobec I, Schiavo G, Forte I, Bihl M, Liguori G, Botti G, Tornillo
L, Karamitopoulou-Diamantis E, Terracciano L and Cillo C: HOX D13
expression across 79 tumor tissue types. Int J Cancer.
125:1532–1541. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cantile M, Schiavo G, Franco R, Cindolo L,
Procino A, D’Armiento M, Facchini G, Terracciano L, Botti G and
Cillo C: Expression of lumbosacral HOX genes, crucial in kidney
organogenesis, is systematically deregulated in clear cell kidney
cancers. Anticancer Drugs. 22:392–401. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cillo C, Schiavo G, Cantile M, Bihl MP,
Sorrentino P, Carafa V, D’ Armiento M, Roncalli M, Sansano S,
Vecchione R, Tornillo L, Mori L, De Libero G, Zucman-Rossi J and
Terracciano L: The HOX gene network in hepatocellular carcinoma.
Int J Cancer. 129:2577–2587. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lawrence HJ, Stage KM, Mathews CH, Detmer
K, Scibienski R, MacKenzie M, Migliaccio E, Boncinelli E and
Largman C: Expression of HOX C homeobox genes in lymphoid cells.
Cell Growth Differ. 4:665–669. 1993.PubMed/NCBI
|
|
23
|
Bijl J, van Oostveen JW, Kreike M, Rieger
E, van der Raaij-Helmer LM, Walboomers JM, Corte G, Boncinelli E,
van den Brule AJ and Meijer CJ: Expression of HOXC4, HOXC5, and
HOXC6 in human lymphoid cell lines, leukemias, and benign and
malignant lymphoid tissue. Blood. 87:1737–1745. 1996.PubMed/NCBI
|
|
24
|
Cillo C, Cantile M, Mortarini R, Barba P,
Parmiani G and Anichini A: Differential patterns of HOX gene
expression are associated with specific integrin and ICAM profiles
in clonal populations isolated from a single human melanoma
metastasis. Int J Cancer. 66:692–697. 1996. View Article : Google Scholar
|
|
25
|
Cantile M, Cindolo L, Napodano G, Altieri
V and Cillo C: Hyperexpression of locus C genes in the HOX network
is strongly associated in vivo with human bladder transitional cell
carcinomas. Oncogene. 22:6462–6468. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miller GJ, Miller HL, van Bokhoven A,
Lambert JR, Werahera PN, Schirripa O, Lucia MS and Nordeen SK:
Aberrant HOXC expression accompanies the malignant phenotype in
human prostate. Cancer Res. 63:5879–5888. 2003.PubMed/NCBI
|
|
27
|
Schiavo G, D’Antò V, Cantile M, Procino A,
Di Giovanni S, Valletta R, Terracciano L, Baumhoer D, Jundt G and
Cillo C: Deregulated HOX genes in ameloblastomas are located in
physical contiguity to keratin genes. J Cell Biochem.
112:3206–3215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fletcher C, Unni K and Mertens F: World
Health Organization Classification of Tumors. Pathology and
Genetics of Tumours of Soft Tissue and Bone. IARC Press; Lyon:
2002
|
|
29
|
Simon R, Struckmann K, Schraml P, Wagner
U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ,
Gasser T and Sauter G: Amplification pattern of 12q13-q15 genes
(MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene.
21:2476–2483. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wikman H, Nymark P, Väyrynen A, Jarmalaite
S, Kallioniemi A, Salmenkivi K, Vainio-Siukola K,
Husgafvel-Pursiainen K, Knuutila S, Wolf M and Anttila S: CDK4 is a
probable target gene in a novel amplicon at 12q13.3-q14.1 in lung
cancer. Genes Chromosomes Cancer. 42:193–199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Muthusamy V, Hobbs C, Nogueira C,
Cordon-Cardo C, McKee PH, Chin L and Bosenberg MW: Amplification of
CDK4 and MDM2 in malignant melanoma. Genes Chromosomes Cancer.
45:447–454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Willmore-Payne C, Holden J, Turner KC,
Proia A and Layfield LJ: Translocations and amplifications of
chromosome 12 in liposarcoma demonstrated by the LSI CHOP
breakapart rearrangement probe. Arch Pathol Lab Med. 132:952–957.
2008.PubMed/NCBI
|
|
33
|
Barr FG, Duan F, Smith LM, Gustafson D,
Pitts M, Hammond S and Gastier-Foster JM: Genomic and clinical
analyses of 2p24 and 12q13-q14 amplification in alveolar
rhabdomyosarcoma: a report from the Children’s Oncology Group.
Genes Chromosomes Cancer. 48:661–672. 2009.PubMed/NCBI
|
|
34
|
Or YY, Chung GT, To KF, Chow C, Choy KW,
Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, Yip TT, Busson P and Lo
KW: Identification of a novel 12p13.3 amplicon in nasopharyngeal
carcinoma. J Pathol. 220:97–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fischer U, Leidinger P, Keller A, Folarin
A, Ketter R, Graf N, Lenhof HP and Meese E: Amplicons on chromosome
12q13-21 in glioblastoma recurrences. Int J Cancer. 126:2594–2602.
2010.PubMed/NCBI
|
|
36
|
Mejia-Guerrero S, Quejada M, Gokgoz N,
Gill M, Parkes RK, Wunder JS and Andrulis IL: Characterization of
the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical
correlations in osteosarcoma. Genes Chromosomes Cancer. 49:518–525.
2010.PubMed/NCBI
|
|
37
|
Batchvarova N, Wang XZ and Ron D:
Inhibition of adipogenesis by the stress-induced protein CHOP
(Gadd153). EMBO J. 14:4654–4661. 1995.PubMed/NCBI
|
|
38
|
Forni C, Minuzzo M, Virdis E, et al:
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma
tumors. Mol Cancer Ther. 8:449–457. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kiess W, Petzold S, Töpfer M, Garten A,
Blüher S, Kapellen T, Körner A and Kratzsch J: Adipocytes and
adipose tissue. Best Pract Res Clin Endocrinol Metab. 22:135–153.
2008. View Article : Google Scholar
|
|
40
|
Cantile M, Procino A, D’Armiento M,
Cindolo L and Cillo C: HOX gene network is involved in the
transcriptional regulation of in vivo human adipogenesis. J Cell
Physiol. 194:225–236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Morgan R, Pirard PM, Shears L, Sohal J,
Pettengell R and Pandha HS: Antagonism of HOX/PBX dimer formation
blocks the in vivo proliferation of melanoma. Cancer Res.
67:5806–5813. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Laurent A, Bihan R, Omilli F, Deschamps S
and Pellerin I: PBX proteins: much more than Hox cofactors. Int J
Dev Biol. 52:9–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Morgan R, Plowright L, Harrington KJ,
Michael A and Pandha HS: Targeting HOX and PBX transcription
factors in ovarian cancer. BMC Cancer. 10:892010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Seyhan AA: RNAi: a potential new class of
therapeutic for human genetic disease. Hum Genet. 30:583–605. 2011.
View Article : Google Scholar : PubMed/NCBI
|
